var singsData = [{"date":new Date(2012,1,29),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.33","showOnAxis":true},{"date":new Date(2012,1,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,1,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,1,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,10,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,10,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains CHRW to Neutral. Target Price is $68.","showOnAxis":false},{"date":new Date(2012,10,9),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades CHRW to Buy from Hold.","showOnAxis":false},{"date":new Date(2012,11,13),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2012,11,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,11,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,3,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $71; previously $70.","showOnAxis":false},{"date":new Date(2012,3,18),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades CHRW to Buy from Hold. Target Price is $79; previously $71.","showOnAxis":false},{"date":new Date(2012,3,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,3,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,3,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CHRW to Underweight. Target Price is $70; previously $72.","showOnAxis":false},{"date":new Date(2012,3,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CHRW to Buy. Target Price is $81; previously $82.","showOnAxis":false},{"date":new Date(2012,3,27),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades CHRW to Hold from Sell.","showOnAxis":false},{"date":new Date(2012,4,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2012 Q1's earning $0.65 per share and revenue $2552MM..","showOnAxis":false},{"date":new Date(2012,4,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2012,4,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,4,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,4,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer initiates coverage on CHRW to Perform.","showOnAxis":false},{"date":new Date(2012,4,17),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich initiates coverage on CHRW to Hold. Target Price is $68.","showOnAxis":false},{"date":new Date(2012,4,30),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.33","showOnAxis":true},{"date":new Date(2012,6,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs assumes CHRW to Neutral. Target Price is $59.","showOnAxis":false},{"date":new Date(2012,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,6,25),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Avondale Partners downgrades CHRW to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Deutsche Bank downgrades CHRW to Hold from Buy. Target Price is $58; previously $77.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CHRW to Neutral. Target Price is $57; previously $65.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CHRW to Underweight. Target Price is $56; previously $70.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CHRW to Hold. Target Price is $64; previously $66.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Sterne Agee maintains CHRW to Neutral. Target Price is $60; previously $63.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CHRW to Buy. Target Price is $73; previously $81.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains CHRW to Hold. Target Price is $68; previously $60.","showOnAxis":false},{"date":new Date(2012,7,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2012 Q2's earning $0.71 per share and revenue $2955MM..","showOnAxis":false},{"date":new Date(2012,7,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,7,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Longbow Research initiates coverage on CHRW to Neutral.","showOnAxis":false},{"date":new Date(2012,8,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,8,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,8,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,8,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,8,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains CHRW to Hold. Target Price is $64; previously $60.","showOnAxis":false},{"date":new Date(2012,8,26),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CHRW to Neutral. Target Price is $62; previously $57.","showOnAxis":false},{"date":new Date(2012,8,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.33","showOnAxis":true},{"date":new Date(2012,9,1),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Sterne Agee upgrades CHRW to Buy from Neutral. Target Price is $65; previously $60.","showOnAxis":false},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,9,17),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades CHRW to Buy from Neutral. Target Price is $71; previously $64.","showOnAxis":false},{"date":new Date(2012,9,17),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CHRW to Buy. Target Price is $72; previously $73.","showOnAxis":false},{"date":new Date(2012,9,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,9,23),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2012 Q3's earning $0.72 per share and revenue $2880MM. This misses analyst's estimated EPS $0.73, misses estimated revenue $2960MM.","showOnAxis":false},{"date":new Date(2012,9,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains CHRW to Neutral. Target Price is $66; previously $56.","showOnAxis":false},{"date":new Date(2012,9,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CHRW to Hold. Target Price is $66; previously $60.","showOnAxis":false},{"date":new Date(2012,9,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Sterne Agee maintains CHRW to Buy. Target Price is $75; previously $66.","showOnAxis":false},{"date":new Date(2012,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2012,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2012,9,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CHRW to Hold. Target Price is $60; previously $64.","showOnAxis":false},{"date":new Date(2012,9,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"JP Morgan upgrades CHRW to Neutral from Underweight. Target Price is $65; previously $56.","showOnAxis":false},{"date":new Date(2013,0,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,0,16),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel downgrades CHRW to Sell from Hold.","showOnAxis":false},{"date":new Date(2013,0,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains CHRW to Neutral. Target Price is $67; previously $63.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2012 Q4's earning $0.68 per share and revenue $2970MM. This misses analyst's estimated EPS $0.7, beats estimated revenue $2870MM.","showOnAxis":false},{"date":new Date(2013,1,6),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Bank of America downgrades CHRW to Underperform from Buy. Target Price is $60; previously $74.","showOnAxis":false},{"date":new Date(2013,1,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CHRW to Hold. Target Price is $61; previously $66.","showOnAxis":false},{"date":new Date(2013,1,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,1,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,10,20),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Deutsche Bank downgrades CHRW to Hold from Buy. Target Price is $60; previously $65.","showOnAxis":false},{"date":new Date(2013,10,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CHRW to Neutral. Target Price is $57; previously $60.","showOnAxis":false},{"date":new Date(2013,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2013 Q3's earning $0.69 per share and revenue $3320MM. This misses analyst's estimated EPS $0.73, beats estimated revenue $3230MM.","showOnAxis":false},{"date":new Date(2013,10,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Buy. Target Price is $65; previously $68.","showOnAxis":false},{"date":new Date(2013,11,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"KeyBanc initiates coverage on CHRW.","showOnAxis":false},{"date":new Date(2013,11,13),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2013,11,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,11,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,11,6),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Bernstein downgrades CHRW to Market Perform from Outperform. Target Price is $63; previously $68.","showOnAxis":false},{"date":new Date(2013,2,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie initiates coverage on CHRW to Neutral. Target Price is $58.","showOnAxis":false},{"date":new Date(2013,3,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Buy. Target Price is $78; previously $72.","showOnAxis":false},{"date":new Date(2013,3,16),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"JP Morgan downgrades CHRW to Underweight from Neutral. Target Price is $50; previously $62.","showOnAxis":false},{"date":new Date(2013,4,13),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"UBS downgrades CHRW to Neutral from Buy. Target Price is $61; previously $72.","showOnAxis":false},{"date":new Date(2013,4,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,4,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2013 Q1's earning $0.64 per share and revenue $2990MM. This misses analyst's estimated EPS $0.69, beats estimated revenue $2980MM.","showOnAxis":false},{"date":new Date(2013,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,5,10),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades CHRW to Underweight from Equal-Weight.","showOnAxis":false},{"date":new Date(2013,5,21),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades CHRW to Sell from Neutral. Target Price is $56; previously $58.","showOnAxis":false},{"date":new Date(2013,5,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2013,6,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research initiates coverage on CHRW to Buy. Target Price is $75.","showOnAxis":false},{"date":new Date(2013,7,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,7,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,7,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2013,7,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2013 Q2's earning $0.7 per share and revenue $3290MM. This misses analyst's estimated EPS $0.73, misses estimated revenue $3340MM.","showOnAxis":false},{"date":new Date(2013,7,7),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Wells Fargo downgrades CHRW to Underperform from Market Perform.","showOnAxis":false},{"date":new Date(2013,7,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,8,30),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"RBC Capital downgrades CHRW to Underperform from Sector Perform. Target Price is $58.","showOnAxis":false},{"date":new Date(2013,8,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2013,9,7),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Macquarie downgrades CHRW to Underperform from Neutral. Target Price is $54; previously $59.5.","showOnAxis":false},{"date":new Date(2014,0,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,1,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich terminates CHRW coverage  from Hold; previously $58.","showOnAxis":false},{"date":new Date(2014,1,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains CHRW to Hold. Target Price is $58; previously $64.","showOnAxis":false},{"date":new Date(2014,1,7),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades CHRW to Hold from Sell.","showOnAxis":false},{"date":new Date(2014,11,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,11,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,11,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,11,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura initiates coverage on CHRW to Neutral. Target Price is $75.","showOnAxis":false},{"date":new Date(2014,11,11),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.38","showOnAxis":true},{"date":new Date(2014,11,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains CHRW to Buy. Target Price is $85; previously $84.","showOnAxis":false},{"date":new Date(2014,11,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains CHRW to Underperform. Target Price is $67; previously $65.","showOnAxis":false},{"date":new Date(2014,11,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2014,11,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,11,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,11,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,11,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,11,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,11,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,11,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,2,31),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"FBR Capital upgrades CHRW to Market Perform from Underperform.","showOnAxis":false},{"date":new Date(2014,2,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2014,3,11),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"BB&T Capital upgrades CHRW to Buy from Hold. Target Price is $63.","showOnAxis":false},{"date":new Date(2014,3,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $56; previously $57.","showOnAxis":false},{"date":new Date(2014,3,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,3,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research maintains CHRW to Buy. Target Price is $70; previously $66.","showOnAxis":false},{"date":new Date(2014,4,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $58; previously $56.","showOnAxis":false},{"date":new Date(2014,4,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CHRW to Hold. Target Price is $60; previously $57.","showOnAxis":false},{"date":new Date(2014,4,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,4,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,5,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2014,6,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $59; previously $58.","showOnAxis":false},{"date":new Date(2014,6,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $62; previously $59.","showOnAxis":false},{"date":new Date(2014,6,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,6,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,6,30),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades CHRW to Neutral from Underperform. Target Price is $68; previously $52.","showOnAxis":false},{"date":new Date(2014,6,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CHRW to Neutral. Target Price is $68; previously $60.","showOnAxis":false},{"date":new Date(2014,6,31),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Edward Jones upgrades CHRW to Hold from Sell.","showOnAxis":false},{"date":new Date(2014,6,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains CHRW to Neutral. Target Price is $65; previously $59.","showOnAxis":false},{"date":new Date(2014,6,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $63; previously $62.","showOnAxis":false},{"date":new Date(2014,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,8,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays initiates coverage on CHRW to Equal-Weight. Target Price is $70.","showOnAxis":false},{"date":new Date(2014,8,3),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades CHRW to Sell from Hold; previously $57.","showOnAxis":false},{"date":new Date(2014,8,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2014,9,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wells Fargo initiates coverage on CHRW to Market Perform.","showOnAxis":false},{"date":new Date(2014,9,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie maintains CHRW to Neutral. Target Price is $64.5; previously $57.","showOnAxis":false},{"date":new Date(2014,9,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,9,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,9,29),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades CHRW to Buy from Neutral.","showOnAxis":false},{"date":new Date(2014,9,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CHRW to Neutral. Target Price is $74; previously $68.","showOnAxis":false},{"date":new Date(2014,9,30),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Buckingham Research downgrades CHRW to Neutral from Buy. Target Price is $77; previously $75.","showOnAxis":false},{"date":new Date(2014,9,30),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Credit Suisse downgrades CHRW to Underperform from Neutral. Target Price is $65; previously $68.","showOnAxis":false},{"date":new Date(2014,9,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $69; previously $63.","showOnAxis":false},{"date":new Date(2015,0,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades CHRW to Overweight from Equal-Weight. Target Price is $80; previously $70.","showOnAxis":false},{"date":new Date(2015,0,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $75; previously $71.","showOnAxis":false},{"date":new Date(2015,0,6),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades CHRW to Neutral from Sell. Target Price is $74; previously $68.","showOnAxis":false},{"date":new Date(2015,0,6),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades CHRW to Sector Perform from Underperform. Target Price is $80; previously $73.","showOnAxis":false},{"date":new Date(2015,1,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS initiates coverage on CHRW to Neutral.","showOnAxis":false},{"date":new Date(2015,1,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,4),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"BB&T Capital downgrades CHRW to Hold from Buy.","showOnAxis":false},{"date":new Date(2015,1,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,1,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,10,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,10,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,10),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.43","showOnAxis":true},{"date":new Date(2015,11,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research initiates coverage on CHRW to Neutral. Target Price is $63.","showOnAxis":false},{"date":new Date(2015,11,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades CHRW to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,11,2),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Bank of America downgrades CHRW to Underperform from Neutral. Target Price is $66; previously $73.","showOnAxis":false},{"date":new Date(2015,11,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,11,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital initiates coverage on CHRW to Outperform. Target Price is $70.","showOnAxis":false},{"date":new Date(2015,2,11),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Cleveland Research downgrades CHRW to Neutral from Buy.","showOnAxis":false},{"date":new Date(2015,2,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.38","showOnAxis":true},{"date":new Date(2015,3,27),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"UBS downgrades CHRW to Sell from Neutral.","showOnAxis":false},{"date":new Date(2015,3,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,3,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,3,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CHRW to Overweight. Target Price is $77; previously $80.","showOnAxis":false},{"date":new Date(2015,3,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CHRW to Neutral. Target Price is $72; previously $76.","showOnAxis":false},{"date":new Date(2015,3,29),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Bank of America downgrades CHRW to Neutral from Buy.","showOnAxis":false},{"date":new Date(2015,3,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $70; previously $74.","showOnAxis":false},{"date":new Date(2015,4,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,4,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,4,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,5,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.38","showOnAxis":true},{"date":new Date(2015,6,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CHRW to Overweight. Target Price is $72; previously $77.","showOnAxis":false},{"date":new Date(2015,6,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,6,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CHRW to Overweight. Target Price is $74; previously $72.","showOnAxis":false},{"date":new Date(2015,7,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Evercore ISI Group initiates coverage on CHRW to Buy. Target Price is $81.","showOnAxis":false},{"date":new Date(2015,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,8,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wolfe Research upgrades CHRW to Outperform.","showOnAxis":false},{"date":new Date(2015,8,2),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.38","showOnAxis":true},{"date":new Date(2015,8,28),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"BB&T Capital upgrades CHRW to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,9,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,9,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,9,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Susquehanna maintains CHRW to Neutral. Target Price is $76; previously $75.","showOnAxis":false},{"date":new Date(2016,0,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CHRW to Hold. Target Price is $70; previously $75.","showOnAxis":false},{"date":new Date(2016,0,7),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades CHRW to Outperform from Sector Perform. Target Price is $75; previously $72.","showOnAxis":false},{"date":new Date(2016,0,7),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades CHRW to Neutral from Sell.","showOnAxis":false},{"date":new Date(2016,1,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,1,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,1,2),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2015 Q4's earning $0.88 per share and revenue $3211MM. This beats analyst's estimated EPS $0.87, misses estimated revenue $3350MM.","showOnAxis":false},{"date":new Date(2016,1,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Raymond James upgrades CHRW to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2016,10,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank initiates coverage on CHRW to Hold.","showOnAxis":false},{"date":new Date(2016,10,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades CHRW to Hold from Buy.","showOnAxis":false},{"date":new Date(2016,10,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"KeyBanc maintains CHRW to Overweight. Target Price is $80; previously $77.","showOnAxis":false},{"date":new Date(2016,11,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45","showOnAxis":true},{"date":new Date(2016,2,2),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.43","showOnAxis":true},{"date":new Date(2016,2,7),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"BMO Capital downgrades CHRW to Market Perform from Outperform. Target Price is $74; previously $72.","showOnAxis":false},{"date":new Date(2016,3,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"KeyBanc upgrades CHRW to Overweight from Sector Perform.","showOnAxis":false},{"date":new Date(2016,3,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research maintains CHRW to Buy. Target Price is $83; previously $80.","showOnAxis":false},{"date":new Date(2016,3,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,3,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,3,26),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2016 Q1's earning $0.83 per share and revenue $3074MM. This beats analyst's estimated EPS $0.82, misses estimated revenue $3190MM.","showOnAxis":false},{"date":new Date(2016,3,27),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"BB&T Capital downgrades CHRW to Hold from Buy.","showOnAxis":false},{"date":new Date(2016,3,28),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stephens & Co. downgrades CHRW to Equal-Weight from Overweight. Target Price is $76.","showOnAxis":false},{"date":new Date(2016,4,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,4,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,5,1),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.43","showOnAxis":true},{"date":new Date(2016,5,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,5,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,6,11),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"UBS downgrades CHRW to Sell from Neutral.","showOnAxis":false},{"date":new Date(2016,6,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan initiates coverage on CHRW to Underweight. Target Price is $66.","showOnAxis":false},{"date":new Date(2016,6,18),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Raymond James downgrades CHRW to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2016,6,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,6,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,6,26),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2016 Q2's earning $1 per share and revenue $3300MM. This misses analyst's estimated EPS $1.01, misses estimated revenue $3430MM.","showOnAxis":false},{"date":new Date(2016,6,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CHRW to Overweight. Target Price is $78; previously $81.","showOnAxis":false},{"date":new Date(2016,7,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains CHRW to Underweight. Target Price is $64; previously $65.","showOnAxis":false},{"date":new Date(2016,7,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,7,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,7,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,7,31),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.43","showOnAxis":true},{"date":new Date(2016,8,12),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades CHRW to Equal-Weight from Overweight. Target Price is $72; previously $78.","showOnAxis":false},{"date":new Date(2016,9,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,9,25),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2016 Q3's earning $0.9 per share and revenue $3356MM. This misses analyst's estimated EPS $0.96, beats estimated revenue $3330MM.","showOnAxis":false},{"date":new Date(2017,0,31),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CHRW reports 2016 Q4's earning $0.86 per share and revenue $3415MM. This beats analyst's estimated EPS $0.84, beats estimated revenue $3330MM.","showOnAxis":false}];